End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.09 MYR | -0.96% | +1.64% | +2.66% |
04-12 | Penumbra, Inc. : The underdog in healthcare | |
02-26 | Inari Amertron Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 32.85 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Semiconductors
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.66% | 2.43B | B+ | ||
+67.61% | 2,044B | B- | ||
+33.22% | 629B | A- | ||
+11.34% | 576B | C | ||
-2.18% | 233B | B- | ||
+2.76% | 160B | A- | ||
-39.59% | 129B | C+ | ||
+28.60% | 121B | B+ | ||
+26.87% | 97.97B | - | - | |
-2.31% | 96.15B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- INARI Stock
- Ratings Inari Amertron